UnitedHealth Group Stock Sinks to 5-Year Lows

Core Insights - UnitedHealth Group Inc (NYSE:UNH) has suspended its 2025 guidance due to unexpected expenditure issues, leading to a significant drop in stock price, down 12.8% to $330.25, with a five-year low of $322.90 reached earlier [1] - CEO Andrew Witty is stepping down for personal reasons, contributing to the negative sentiment surrounding the company [1] Stock Performance - The stock is experiencing its sixth consecutive loss, with a 14-Day Relative Strength Index (RSI) at 14, indicating it is in "oversold" territory [2] - UNH shares have declined by 36% in 2025, yet analysts have not issued any bearish notes or downgrades, with 22 out of 24 analysts maintaining a "buy" or better rating [3] Analyst Ratings and Price Targets - The consensus 12-month price target for UNH is $549.91, representing a 70% premium over the current price, suggesting potential pressure from future bearish notes [3] Options Market Activity - There is a strong preference for long calls in the options market, with a 10-day call/put volume ratio of 2.90, nearing an annual high [4] - Today's options trading volume is significantly high, with over 120,000 calls and 70,000 puts exchanged, which is eight times the average intraday amount [5] - The May 300 put is the most popular option, while the May 360 call is also seeing notable activity, indicating a strategic interest in options trading [5]